Vishal Chaturvedi’s low-budget devotional drama Hanuman Ansh continued its improbable seventh-week run on September 23, crossing about ₹366.45 crore worldwide and overtaking Geethu Mohandas’s pan-India action film Toxic: A Fairytale for Grownups in global gross—while Amazon MGM’s Mirzapur: The Movie held near ₹315 crore worldwide as exhibitors braced for Vvan’s September 25 opener during the Dasara holiday corridor.
Hanuman Ansh versus Toxic
Trade trackers cited by The Indian Express put Hanuman Ansh at roughly ₹280.93 crore net domestically and ₹366.45 crore globally after 47 days, compared with Toxic’s approximate ₹342.07 crore worldwide total on a reported ₹500-crore budget. Hanuman Ansh opened to a whisper—about ₹10 lakh on day one, per industry accounts—before word-of-mouth and strategic expansion, including overseas distribution by Hombale Films from September 11, turned it into a case study in recovery multiples.
Toxic, starring Yash with a stacked ensemble, debuted with a triple-digit crore opening in August but faced screen erosion as exhibitors extended Hanuman Ansh and Mirzapur holds. The reversal is narrative gold for producers betting on faith audiences over franchise spectacle, though exhibitors caution that slate concentration in September squeezes mid-budget releases.
Mirzapur’s theatrical translation
Mirzapur: The Movie, bringing Pankaj Tripathi and Ravi Kishan’s streaming crime saga to cinemas, collected roughly ₹315 crore worldwide by industry estimates on days 18–19 of its run, with Business Today citing about ₹219.70 crore net in India and ₹58.25 crore overseas. The film’s “bhaukaal” marketing leaned on fan rituals from the Prime Video series, converting urban binge-watchers into holiday ticket buyers.
Exhibitors in Uttar Pradesh and Bihar reported strong matinee occupancy through the pre-Dasara week, even as Mumbai multiplexes balanced Hindi dubs of southern holdovers.
Dasara window and Vvan
Vvan’s September 25 release adds a third headline competitor for screens and marketing oxygen. Distributors negotiate week-four shares daily; Hanuman Ansh’s stake is to push toward a ₹400-crore worldwide talking point, while Mirzapur fights to cross ₹350 crore before audience attention fractures.
Producer interviews in Screen—quoted by the Express—acknowledged initial fear that Toxic would swamp their slot; the outcome underscores how calendar luck and grassroots booking in tier-3 towns can beat star wattage when festivals align.
What audiences are buying
Hanuman Ansh sells spiritual biography; Mirzapur sells ultraviolent nostalgia; Toxic sold stylised action myth-making. Together they map three Indian box-office pipelines that rarely share the same audience but compete for the same physical seats. For the industry, the lesson this Dasara is not that budgets do not matter—it is that longevity and corridor planning can matter more than opening fireworks.
Overseas, Hanuman Ansh’s ₹34.75 crore international tally benefited from diaspora bookings in the United States and Gulf corridors once Hombale picked up distribution—a reminder that Indian hits now chase global spiritual tourism calendars, not only domestic holiday spikes.